| |
| |
|
| Insider
Information: |
Barnett Eva Renee |
| Relationship: |
Chief Financial Officer |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
359,456 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
359,456 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunovant Inc |
IMVT |
Chief Financial Officer |
2024-04-17 |
359,456 |
2021-10-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2024-04-17 |
4 |
S |
$28.80 |
$356,049 |
D/D |
(12,253) |
359,456 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2024-04-09 |
4 |
S |
$31.18 |
$115,023 |
D/D |
(3,689) |
371,709 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2024-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
54,978 |
375,398 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2024-02-22 |
4 |
S |
$36.15 |
$105,920 |
D/D |
(2,930) |
320,420 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2024-01-11 |
4 |
S |
$41.64 |
$147,023 |
D/D |
(3,515) |
323,350 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2023-11-22 |
4 |
S |
$32.75 |
$132,920 |
D/D |
(4,055) |
326,865 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2023-10-10 |
4 |
S |
$36.92 |
$168,244 |
D/D |
(4,557) |
330,920 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2023-08-24 |
4 |
S |
$20.30 |
$292,036 |
D/D |
(14,386) |
335,477 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2023-07-19 |
4 |
S |
$24.94 |
$67,962 |
D/D |
(2,725) |
349,863 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2023-04-18 |
4 |
S |
$15.27 |
$52,269 |
D/D |
(3,423) |
352,588 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2023-04-12 |
4 |
A |
$0.00 |
$0 |
D/D |
87,664 |
356,011 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2023-01-11 |
4 |
S |
$15.15 |
$75,525 |
D/D |
(4,510) |
268,347 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2022-10-11 |
4 |
S |
$9.44 |
$118,000 |
D/D |
(12,500) |
272,857 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2022-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
112,816 |
285,357 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2022-01-07 |
4 |
S |
$7.25 |
$217,203 |
D/D |
(29,959) |
172,541 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2021-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
143,000 |
202,500 |
0 |
- |
|
| IMVT |
Immunovant Inc |
Chief Financial Officer |
• – – |
2021-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
59,500 |
59,500 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
